| Mrs Kelly M Hochstetler, PA-C | |
|
789 Central Ave, Dover, NH 03820-2526 | |
| (603) 609-6819 | |
| Not Available |
| Full Name | Mrs Kelly M Hochstetler |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 16 Years |
| Location | 789 Central Ave, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659518280 | NPI | - | NPPES |
| 3077613 | Medicaid | NH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wentworth Douglass Physician Corporation | 5496749848 | 372 |
News Archive
Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.
The federal government is trying to spur enrollment in a new health insurance program for uninsured people with pre-existing medical conditions by slashing rates.
Just a day after announcing that President Barack Obama would meet with state insurance regulators in Seattle next week, the White House said Friday that the meeting would have to come later.
All current breast cancer drugs were first tested in cell lines. Each cell line began as cancer in a patient. As such, each cell line is a surrogate for that patient's disease.
A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelly M Hochstetler, PA-C 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 609-6819 | Mrs Kelly M Hochstetler, PA-C 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 609-6819 |
News Archive
Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.
The federal government is trying to spur enrollment in a new health insurance program for uninsured people with pre-existing medical conditions by slashing rates.
Just a day after announcing that President Barack Obama would meet with state insurance regulators in Seattle next week, the White House said Friday that the meeting would have to come later.
All current breast cancer drugs were first tested in cell lines. Each cell line began as cancer in a patient. As such, each cell line is a surrogate for that patient's disease.
A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature.
› Verified 8 days ago